Filed: 2/12/2026ACC: 0001104659-26-014058
📋 What this filing means
KNOTT DAVID M JR filed this quarterly 13F‑HR report disclosing 87 equity positions with a total reported market value of $215.94M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
87
Positions
$215.94M
Total AUM (reported)
11.07M
Total Shares
Allocation by class
COMMON$215.94M100.0%
Portfolio Concentration
Top 3$105.27M48.7%
4–10$47.32M21.9%
11–25$36.58M16.9%
Rest$26.77M12.4%
Top 3 weight
48.7%
Top 10 weight
70.7%
Voting Authority Distribution
Total shares with voting rights: 11.07M
Sole
Full voting authority
11.07M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other87
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings87
Rows:
Calumet, Inc.
DFNDShares2.21M
TypeSH
Market value$44.01M
20.38%
Sole
2.21M
Shared
0.00
None
0.00
Apollo Global Management, Inc.
DFNDShares225K
TypeSH
Market value$32.57M
15.08%
Sole
225K
Shared
0.00
None
0.00
Alphabet Inc-Cl C
DFNDShares91.42K
TypeSH
Market value$28.69M
13.28%
Sole
91.42K
Shared
0.00
None
0.00
Syndax Pharmaceutical, Inc.
DFNDShares415K
TypeSH
Market value$8.72M
4.04%
Sole
415K
Shared
0.00
None
0.00
Xeris Biopharma Holdings, Inc.
DFNDShares970K
TypeSH
Market value$7.61M
3.53%
Sole
970K
Shared
0.00
None
0.00
Travere Therapeutics, Inc.
DFNDShares186K
TypeSH
Market value$7.11M
3.29%
Sole
186K
Shared
0.00
None
0.00
Bridgebio Pharma, Inc.
DFNDShares85K
TypeSH
Market value$6.50M
3.01%
Sole
85K
Shared
0.00
None
0.00
Protagonist Therapeutics, Inc
DFNDShares73K
TypeSH
Market value$6.38M
2.95%
Sole
73K
Shared
0.00
None
0.00
JPMorgan Chase & Co.
DFNDShares19.48K
TypeSH
Market value$6.28M
2.91%
Sole
19.48K
Shared
0.00
None
0.00
Janus Henderson AAA CLO ETF
DFNDShares93.53K
TypeSH
Market value$4.73M
2.19%
Sole
93.53K
Shared
0.00
None
0.00
Viridian Therapeutics, Inc.
DFNDShares145K
TypeSH
Market value$4.51M
2.09%
Sole
145K
Shared
0.00
None
0.00
Catalyst Pharmaceuticals, Inc.
DFNDShares189K
TypeSH
Market value$4.41M
2.04%
Sole
189K
Shared
0.00
None
0.00
Cogent Biosciences Inc.
DFNDShares102K
TypeSH
Market value$3.62M
1.68%
Sole
102K
Shared
0.00
None
0.00
Arcus Biosciences, Inc.
DFNDShares121.24K
TypeSH
Market value$2.89M
1.34%
Sole
121.24K
Shared
0.00
None
0.00
Alkermes PLC
DFNDShares95K
TypeSH
Market value$2.66M
1.23%
Sole
95K
Shared
0.00
None
0.00
DocGo, Inc.
DFNDShares2.67M
TypeSH
Market value$2.34M
1.09%
Sole
2.67M
Shared
0.00
None
0.00
Cybin Inc
DFNDShares285.18K
TypeSH
Market value$2.33M
1.08%
Sole
285.18K
Shared
0.00
None
0.00
Cytokinetics, Incorporated
DFNDShares34K
TypeSH
Market value$2.16M
1.00%
Sole
34K
Shared
0.00
None
0.00
AtriCure, Inc.
DFNDShares51.40K
TypeSH
Market value$2.03M
0.94%
Sole
51.40K
Shared
0.00
None
0.00
AllianceBernstein Holding L.P.
DFNDShares48K
TypeSH
Market value$1.85M
0.86%
Sole
48K
Shared
0.00
None
0.00
Arcellx Inc
DFNDShares25.70K
TypeSH
Market value$1.68M
0.78%
Sole
25.70K
Shared
0.00
None
0.00
SPDR S&P Biotech ETF
DFNDShares13K
TypeSH
Market value$1.59M
0.73%
Sole
13K
Shared
0.00
None
0.00
Tectonic Therapeutic, Inc.
DFNDShares74K
TypeSH
Market value$1.54M
0.71%
Sole
74K
Shared
0.00
None
0.00
Wave Life Science Ltd.
DFNDShares90K
TypeSH
Market value$1.53M
0.71%
Sole
90K
Shared
0.00
None
0.00
Johnson & Johnson
DFNDShares6.92K
TypeSH
Market value$1.43M
0.66%
Sole
6.92K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Calumet, Inc.DFND | Common | 2.21M | SH | $44.01M 20.38% | 2.21M | 0.00 | 0.00 |
Apollo Global Management, Inc.DFND | Common | 225K | SH | $32.57M 15.08% | 225K | 0.00 | 0.00 |
Alphabet Inc-Cl CDFND | Common | 91.42K | SH | $28.69M 13.28% | 91.42K | 0.00 | 0.00 |
Syndax Pharmaceutical, Inc.DFND | Common | 415K | SH | $8.72M 4.04% | 415K | 0.00 | 0.00 |
Xeris Biopharma Holdings, Inc.DFND | Common | 970K | SH | $7.61M 3.53% | 970K | 0.00 | 0.00 |
Travere Therapeutics, Inc.DFND | Common | 186K | SH | $7.11M 3.29% | 186K | 0.00 | 0.00 |
Bridgebio Pharma, Inc.DFND | Common | 85K | SH | $6.50M 3.01% | 85K | 0.00 | 0.00 |
Protagonist Therapeutics, IncDFND | Common | 73K | SH | $6.38M 2.95% | 73K | 0.00 | 0.00 |
JPMorgan Chase & Co.DFND | Common | 19.48K | SH | $6.28M 2.91% | 19.48K | 0.00 | 0.00 |
Janus Henderson AAA CLO ETFDFND | Common | 93.53K | SH | $4.73M 2.19% | 93.53K | 0.00 | 0.00 |
Viridian Therapeutics, Inc.DFND | Common | 145K | SH | $4.51M 2.09% | 145K | 0.00 | 0.00 |
Catalyst Pharmaceuticals, Inc.DFND | Common | 189K | SH | $4.41M 2.04% | 189K | 0.00 | 0.00 |
Cogent Biosciences Inc.DFND | Common | 102K | SH | $3.62M 1.68% | 102K | 0.00 | 0.00 |
Arcus Biosciences, Inc.DFND | Common | 121.24K | SH | $2.89M 1.34% | 121.24K | 0.00 | 0.00 |
Alkermes PLCDFND | Common | 95K | SH | $2.66M 1.23% | 95K | 0.00 | 0.00 |
DocGo, Inc.DFND | Common | 2.67M | SH | $2.34M 1.09% | 2.67M | 0.00 | 0.00 |
Cybin IncDFND | Common | 285.18K | SH | $2.33M 1.08% | 285.18K | 0.00 | 0.00 |
Cytokinetics, IncorporatedDFND | Common | 34K | SH | $2.16M 1.00% | 34K | 0.00 | 0.00 |
AtriCure, Inc.DFND | Common | 51.40K | SH | $2.03M 0.94% | 51.40K | 0.00 | 0.00 |
AllianceBernstein Holding L.P.DFND | Common | 48K | SH | $1.85M 0.86% | 48K | 0.00 | 0.00 |
Arcellx IncDFND | Common | 25.70K | SH | $1.68M 0.78% | 25.70K | 0.00 | 0.00 |
SPDR S&P Biotech ETFDFND | Common | 13K | SH | $1.59M 0.73% | 13K | 0.00 | 0.00 |
Tectonic Therapeutic, Inc.DFND | Common | 74K | SH | $1.54M 0.71% | 74K | 0.00 | 0.00 |
Wave Life Science Ltd.DFND | Common | 90K | SH | $1.53M 0.71% | 90K | 0.00 | 0.00 |
Johnson & JohnsonDFND | Common | 6.92K | SH | $1.43M 0.66% | 6.92K | 0.00 | 0.00 |
Page 1 of 4